Why Transparent Pricing Matters for Weight Management
Is Mounjaro or Wegovy Better: Understanding Hidden Fee Anxiety
When comparing Mounjaro versus Wegovy, many patients discover unexpected costs after choosing their treatment. Traditional online pharmacies often advertise low medication prices but add consultation fees (£30-50), prescription charges (£15-25), and admin fees at checkout. EverydayMeds eliminates this anxiety with all-inclusive pricing. Our Wegovy costs £79.99 for the 0.25mg starter dose, £94.99 for 0.5mg, and £99.99 for 1mg - these prices include your complete clinical pathway.
This transparent approach extends to both treatments we offer. Whether you're considering Mounjaro (tirzepatide, a dual GIP/GLP-1 receptor agonist) or Wegovy (semaglutide, a GLP-1 receptor agonist), you'll see exactly what you pay upfront. No hidden consultation fees, no surprise prescription charges, no admin costs added during checkout.
Wegovy Pricing Structure: Complete Transparency for Better Planning
Understanding the full cost helps you plan your weight management journey effectively. Our Wegovy pricing includes the mandatory dose escalation: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and 2.4mg maintenance (£209.99). These prices include clinical assessment, prescriber review, prescription, and next-day delivery. Apply code FIRST40 at checkout for new customers or DOSE25 for returning patients.
We also offer convenient bundles like the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. Each bundle provides seamless progression through dose escalation without multiple orders. Compare this to competitors charging separate consultation fees for each prescription - potentially adding £150-200 to your total treatment cost.
Clinical Evidence: Is Mounjaro or Wegovy Better Supported by Research?
Both treatments demonstrate significant efficacy in clinical trials, though direct comparison remains difficult due to different trial designs and populations. Wegovy's STEP trials showed patients achieved approximately 15% average weight loss at 68 weeks when combined with reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The SELECT trial additionally demonstrated 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials indicated substantial weight management benefits with its dual hormone approach, targeting both GIP and GLP-1 receptors. However, comparing percentage outcomes between trials can be misleading due to different methodologies, baseline characteristics, and endpoints. Both remain prescription-only medicines requiring individual clinical assessment.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. After injection, it activates receptors in your brain's appetite centres, promoting feelings of satiety and reducing food cravings. This mechanism helps you feel satisfied with smaller portions during meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged fullness. Unlike Mounjaro's dual approach targeting both GIP and GLP-1 pathways, Wegovy focuses specifically on GLP-1 receptors with proven cardiovascular benefits in the SELECT trial.
Streamlined Ordering Process: No Hidden Steps or Charges
Our transparent process matches our pricing philosophy - everything included, nothing hidden. Complete a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Your assessment undergoes review by qualified prescribers (standard 3 working days, express 24-hour option available). Once approved, we dispatch your Wegovy via next-day delivery using temperature-controlled cold-chain logistics. This entire process - assessment, prescription, medication, delivery - is included in the prices listed above. No additional consultation fees appear at any stage.
Storage and Practical Considerations: Wegovy's Travel Advantage
Wegovy offers practical storage benefits when deciding between treatments. Store unopened pens in your fridge at 2-8°C, but once removed, Wegovy remains stable at room temperature (below 30°C) for up to 6 weeks - significantly longer than Mounjaro's 21-day room temperature limit. This advantage proves valuable for business travel, holidays, or daily convenience. The FlexTouch pen delivers precise weekly injections with dose escalation over 16 weeks: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance. Each pen contains 4 doses, providing monthly supply convenience.
Why Hidden Fees Matter When Choosing Between Mounjaro or Wegovy
Unexpected costs can derail weight management plans, especially during long-term treatment. Many patients budget for advertised medication prices but face shock at checkout when consultation fees double their expected spend. This financial stress undermines treatment adherence - a critical factor for sustained weight management success.
Our transparent pricing eliminates this barrier for both Mounjaro and Wegovy. Whether you choose semaglutide's targeted GLP-1 approach or tirzepatide's dual mechanism, you'll know your exact costs upfront. This financial clarity allows proper budgeting for your health journey without hidden surprises affecting your commitment to treatment.
Start Your Transparent Weight Management Journey Today
Both Mounjaro and Wegovy are available through EverydayMeds with identical transparency - no consultation fees, no prescription charges, no admin costs. Your prescriber will help determine which treatment suits your individual needs during the clinical assessment. Use code FIRST40 for new customers or DOSE25 for returning patients at checkout. Our GPhC-registered pharmacy (#9012878) ensures safe, regulated access to prescription-only medicines alongside the dietary and lifestyle changes essential for successful weight management. Begin your assessment today at our secure online platform with complete confidence in our transparent pricing structure.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
